We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Ruairi J Mackenzie

Ruairi J Mackenzie

Senior Science Writer

Contact Us

Ruairi started with Technology Networks in January 2018 after completing an undergraduate degree in neuroscience at the University of Edinburgh and a master’s degree in clinical neuroscience from the University of Cambridge. As senior science writer, Ruairi covers a range of scientific news and articles, with a focus on the complexities and curiosities of the brain. Ruairi also looks after search engine optimization (SEO) efforts on Technology Networks and created the site’s podcast, Opinionated Science, in 2020.


Latest Content
Vagus Nerve Stimulation Breakthrough Suggests Route To Therapies for Arthritis, Heart Failure
Article

Vagus Nerve Stimulation Breakthrough Suggests Route To Therapies for Arthritis, Heart Failure

A new paper provides timely evidence to explain the therapeutic benefits of vagal nerve stimulation (VNS), a nervous system-modifying treatment that proponents say could offer relief to patients with lupus, arthritis and even heart failure.

Can Teletherapy Help People With OCD During the COVID-19 Pandemic?
Industry Insight

Can Teletherapy Help People With OCD During the COVID-19 Pandemic?

Whilst the coronavirus pandemic and associated lockdown has taken a toll on everyone’s mental health, the burden has been especially heavy for people living with obsessive compulsive disorder (OCD). We spoke to NOCD’s founder Stephen Smith, who has experienced the crippling impact of OCD in his own life, on how his remote counselling service could help people with OCD during the pandemic.
Neuroscience, Science Communication and #ShutdownSTEM
Article

Neuroscience, Science Communication and #ShutdownSTEM

In the wake of #ShutdownSTEM, we share some important resources and look towards the impact of the movement on science and science communication.
Cow-derived COVID-19 Candidate Treatment Produces Four Times More Neutralizing Antibody, Suggests Data
News

Cow-derived COVID-19 Candidate Treatment Produces Four Times More Neutralizing Antibody, Suggests Data

A candidate treatment that utilizes cow antibodies to combat COVID-19 may be able to produce four times the level of neutralizing antibodies as seen in conventional human convalescent plasma serum, the compound's developer has announced.
Telehealth’s Time Is Now. Can It Take a Leading Role?
Industry Insight

Telehealth’s Time Is Now. Can It Take a Leading Role?

Telehealth is booming. An industry which has long shown its value in long-distance and rural healthcare settings has been moved center stage by the COVID-19 pandemic. We spoke to Daniel Carlin, CEO of provider WorldClinic to discuss the need for care consistency in telehealth, the impact of COVID-19 and whether bespoke telehealth services can become truly mainstream.
How Automation Can Give Bioengineering a Boost
Industry Insight

How Automation Can Give Bioengineering a Boost

Genetic technologies have advanced to the point that digital and experimental approaches can work hand-in-hand. We spoke to Emilie Fritsch, a field application scientist at Synthace, to find out more.
Opinionated Science Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials
Podcast

Opinionated Science Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials

In this episode, the Technology Networks team discuss drug treatments to combat SARS-CoV-2. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic?
Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies
News

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

Testing of the malaria drug hydroxychloroquine as a treatment for COVID-19 has been restarted by the WHO after researchers raised concerns about the paper, published in The Lancet two weeks ago, that first suggested the drug was linked to reduced survival and a higher risk of heart-related side effects.
Solving the Biggest Problems in Data Integrity
Infographic

Solving the Biggest Problems in Data Integrity

Data integrity has become an important target for companies across biotech, pharma and biomedical research. The headline goal of making sure that data is up to scratch comes with hidden problems and pitfalls that Technology Networks have now assembled in this infographic, alongside useful ways in which companies can overcome these issues and stay compliant with regulators.

Inner Speech, Internal Monologues and “Hearing Voices”: Exploring the Conversations Between Our Ears
Article

Inner Speech, Internal Monologues and “Hearing Voices”: Exploring the Conversations Between Our Ears

We don’t often outwardly discuss the conversation inside our heads. New research has aimed to better define what our "inner speech" is and what areas of the brain are responsible for it.
Advertisement